Professional role
At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year[1]
LM
for which he has discovered novel antibodies in patients
Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University
mechanisms of synapse formation · other muscular dystrophies such as congenital myasthenia syndrome and ALS · pathophysiological mechanisms of brain disorders, including schizophrenia and autism · pathophysiological mechanisms of myasthenia gravis
Reviewed sources document mechanisms of synapse formation, other muscular dystrophies such as congenital myasthenia syndrome and ALS, pathophysiological mechanisms of brain disorders, including schizophrenia and autism, and pathophysiological mechanisms of myasthenia gravis. Explore attributed publications and research affiliations.
Explore researchAt present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year[1]
chair of the Department of Neurosciences[1]
director of the Cleveland Brain Health Initiative[1]
joins Case Western Reserve University School of Medicine as professor[1]
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years.[1]
mechanisms of synapse formation[1]
other muscular dystrophies such as congenital myasthenia syndrome and ALS[1]
pathophysiological mechanisms of brain disorders, including schizophrenia and autism[1]
pathophysiological mechanisms of myasthenia gravis[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
14 source claims · Reviewed Sep 9, 2026
Biographical context: for which he has discovered novel antibodies in patients
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Biographical context: Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Degree: MD
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Degree: PhD
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Identity: Lin Mei
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Professional role: At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Professional role: chair of the Department of Neurosciences
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Professional role: director of the Cleveland Brain Health Initiative
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Professional role: joins Case Western Reserve University School of Medicine as professor
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Professional role: Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years.
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Research interests: mechanisms of synapse formation
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Research interests: other muscular dystrophies such as congenital myasthenia syndrome and ALS
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Research interests: pathophysiological mechanisms of brain disorders, including schizophrenia and autism
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.
Research interests: pathophysiological mechanisms of myasthenia gravis
Lin Mei, MD, PhD, joins Case Western Reserve University School of Medicine as professor, chair of the Department of Neurosciences, and director of the Cleveland Brain Health Initiative. Mei comes to the medical school following 13 highly productive years at Medical College of Georgia at Augusta University where, since 2014, he served as professor and inaugural chair of the Department of Neuroscience and Regenerative Medicine. Before then, he was director of the school’s Institute of Molecular Medicine and Genetics for five years. He focuses on two main lines of research. First are mechanisms of synapse formation, using the neuromuscular junction, which is critical for accurate and rapid control of muscle contraction, as a model. In this realm, he studies several topics, including pathophysiological mechanisms of myasthenia gravis (for which he has discovered novel antibodies in patients) and other muscular dystrophies such as congenital myasthenia syndrome and ALS. His second line of research is pathophysiological mechanisms of brain disorders, including schizophrenia and autism. At present he is PI and co-PI of five NIH grants and a VA grant totaling $1.8 M per year.